GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP3, GSK3B, HSD11B2, HSD17B2, IDO1, IGF1R, INSR, MAOB, MMP2, MMP9, PPARA, PTGS2, SRC, TEK, TYR |
10.9776 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP3, FABP4, GSK3B, HSD11B2, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TYR |
10.0473 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, GSK3B, HCAR2, HSPA1A, INSR, KDR, MET, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.80054 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, DHFR, EGFR, ESR1, F10, F3, FABP3, FABP4, GPR35, GSK3B, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MAOB, MET, PPARA, PTGS2, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.80054 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, GSK3B, HCAR2, HSPA1A, INSR, KDR, MET, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.80054 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
9.6815 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, F3, FABP3, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PDE5A, PTGS2, SMAD3, SRC, TEK, XDH |
9.10075 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP3, FABP4, GSK3B, HSD11B2, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MMP2, MMP9, PPARA, PTGS2, SMAD3, SRC, TEK, TYR |
8.857 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.857 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.4935 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA, PTGS2 |
8.48 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, GSK3B, HSD11B2, IGF1R, INSR, MAOB, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
8.35779 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IDO1, MAOB, PTGS2, SRC, TYR |
7.81992 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.51448 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, INSR, MAOB, PPARA, PTGS2, SRC, TEK |
7.50943 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, F10, F3, GPR35, GSK3B, HSPA1A, INSR, KDR, MET, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.50943 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, F3, FABP4, GPR35, GSK3B, HSPA1A, IDO1, INSR, KDR, MET, MMP2, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.34603 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, MAOB, PTGS2, TYR, XDH |
7.34603 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FUT7, GBA2, GSK3B, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
7.25524 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.07112 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CDK6, CYP19A1, DHFR, DUSP3, EGFR, ESR1, F3, FABP4, GSK3B, HSPA1A, IDO1, IGF1R, MET, MMP2, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.07112 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.07112 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, HSD11B2, MAOB, PTGS2, SRC, TEK, TYR |
6.98351 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.95989 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, GPR35, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.95989 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
6.80229 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
6.71374 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.67164 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.64877 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.62839 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FUT7, GBA2, HSPA1A, IDO1, PDE5A, PPARA, PTGS2, TYR, XDH |
6.62839 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.62839 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.54936 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DHFR, DUSP3, EGFR, ESR1, F10, F3, FUT7, GBA2, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
6.39828 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.39828 |
[BP] GO:0048513 |
animal organ development
|
ACHE, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, HSD11B1, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
6.39828 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESRRA, ESRRB, GBA2, GSK3B, HSD11B1, HSD17B2, INSR, KDR, MAOB, MMP9, PPARA, PTGS2, SMAD3, SRC, TEK, TYR |
6.39828 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.29708 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, BCL2, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, IDO1, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PDE5A, PPARA, PTGS2, SMAD3, SRC, TEK, TNKS2, TYR |
6.29546 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.27771 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
6.21859 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.16257 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, BCL2, CYP1B1, EGFR, F10, F3, GPR35, HSPA1A, INSR, KDR, MET, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
6.12728 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.09692 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, DHFR |
6.08797 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.04485 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
5.93657 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MAOB, MMP9, PTGS2, SRC |
5.89943 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
5.80694 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, BCL2, CA2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FUT7, GBA2, GSK3B, HSD11B1, HSD17B2, INSR, KDR, MAOB, MET, MMP2, MMP9, PPARA, PTGS2, SMAD3, SRC, TEK, TNKS2, TYR |
5.76565 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MAOB, MET, MMP9, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.71948 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
5.65368 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.6169 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.56506 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, GSK3B, HSPA1A, IDO1, MAOB, MMP1, MMP2, MMP9, PDE5A, SRC, XDH |
5.52029 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.47159 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
5.36564 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.36218 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
5.26001 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, KDR, MAOB, MET, MMP9, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.1167 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, BCL2, CDC25B, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, F3, FABP4, GSK3B, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
5.08266 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, F10, F3, FABP3, FABP4, GSK3B, HSD11B2, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TYR |
5.07467 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DHFR, DUSP3, EGFR, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PTGS2, PTPN1, SRC, TEK, TNKS, XDH |
5.04269 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.04269 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.04269 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, GSK3B, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PTGS2, SMAD3, SRC |
4.99071 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CDK6, CYP19A1, DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.99071 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
4.96714 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.91766 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, BCL2, CA2, CA7, CDK6, EGFR, HCAR2, KDR, PTGS2, SRC, TNKS, TNKS2 |
4.91766 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, GSK3B, KDR, SMAD3, SRC, TEK |
4.8813 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, BCL2, CDC25B, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, GPR35, GSK3B, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
4.87933 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.87584 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.76486 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DHFR, DUSP3, EGFR, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PTGS2, PTPN1, SRC, TEK, TNKS, XDH |
4.7433 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, DHFR, EGFR, INSR, PTGS2, SMAD3, XDH |
4.67288 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, IGF1R, INSR, KDR, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.64266 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, BCL2, CDC25B, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.6146 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, IGF1R, INSR, KDR, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.59296 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
4.5675 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, BCL2, CA2, CDK6, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, INSR, KDR, MET, MMP9, PDE5A, PTGS2, SMAD3, SRC, TEK, TNKS2, XDH |
4.5673 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
4.55667 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DHFR, EGFR, PPARA, SMAD3 |
4.51385 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, HSPA1A, IDO1, MAOB |
4.50306 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.50306 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ESR1, F3, IGF1R, INSR, KDR, MMP2, MMP9, PTGS2, TEK |
4.48308 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DHFR, EGFR, FABP3, GSK3B, HSD11B2, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR |
4.47626 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, GSK3B, HSD11B2, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
4.34888 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, IDO1, MMP2, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
4.31355 |
[BP] GO:0030155 |
regulation of cell adhesion
|
BCL2, CDK6, CYP1B1, DUSP3, GSK3B, IDO1, KDR, NUAK1, PDE5A, PPARA, SMAD3, SRC, TEK |
4.30077 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, EGFR, GSK3B, IGF1R, INSR, KDR, SRC, TEK |
4.26385 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, BCL2, CDK6, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, GSK3B, IGF1R, INSR, KDR, MMP2, PTGS2, SMAD3, SRC |
4.22348 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
CDK6, GSK3B, KDR, SMAD3, TEK |
4.12471 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DHFR, EGFR, FABP3, GSK3B, HSD11B2, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR |
4.12029 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, BCL2, CDC25B, EGFR, ESRRB, FABP3, INSR, KDR, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.0848 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, BCL2, CDC25B, EGFR, ESRRB, FABP3, INSR, KDR, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.0848 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FUT7, GBA2, MET, PPARA, PTGS2 |
4.07211 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.06191 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
4.05913 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.05886 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, BCL2, CDC25B, DHFR, EGFR, ESR1, ESR2, F3, GSK3B, HSPA1A, INSR, MET, MMP9, PDE5A, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
4.0481 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IDO1, PPARA, PTGS2, SMAD3, TEK |
3.99782 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, HSD11B2, MAOB, PTGS2, SRC |
3.96212 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
EGFR, F10, F3, INSR, MET, SRC, TEK |
3.91405 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, BCL2, CDK6, CYP1A1, CYP1B1, DHFR, EGFR, FABP3, HSD11B2, KDR, MAOB, PTGS2, SRC |
3.90929 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
BCL2, GSK3B, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.90929 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
3.90929 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, F3, GSK3B, HSPA1A, INSR, KDR, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.90827 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, BCL2, CA2, CYP1A1, EGFR, HSD11B2, HSPA1A, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TYR |
3.90827 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, HSD11B2, MAOB, PTGS2, SRC |
3.87733 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, GSK3B, IGF1R, MET, MMP9, PPARA, PTGS2, PTPN1, SRC, TNKS |
3.81835 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
3.81433 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, DHFR, GBA2, MAOB, TYR |
3.79673 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MAOB, MMP9, PTGS2 |
3.79006 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, MAOB, XDH |
3.77108 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, MAOB |
3.76679 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
3.76679 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.76679 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.76679 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP4, IGF1R, INSR, KDR, MMP9, PDE5A, PPARA, PTGS2, PTPN1, SRC, TEK, XDH |
3.74442 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
CDK6, DHFR, DUSP3, EGFR, GSK3B, HSPA1A, IGF1R, MET, NUAK1, PTGS2, PTPN1, XDH |
3.71679 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, IDO1, INSR, MMP2, MMP9, PTGS2, SRC |
3.69295 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, BCL2, CSNK2A1, EGFR, ESRRB, GSK3B, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
3.67966 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, ESR1, F3, FABP4, IDO1, KDR, MET, PPARA, PTGS2, SMAD3, TEK |
3.66782 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, BCL2, CDC25B, EGFR, ESR1, F3, GSK3B, HSPA1A, INSR, KDR, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.65115 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, BCL2, CA2, CDK6, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, FABP4, GSK3B, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC |
3.64504 |
[BP] GO:0006468 |
protein phosphorylation
|
BCL2, CDC25B, CDK6, CSNK2A1, EGFR, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
3.57887 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, GSK3B, HSPA1A, IDO1, MAOB, PDE5A, XDH |
3.57291 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.56911 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, EGFR, INSR, MAOB, PTGS2, SMAD3 |
3.56904 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
3.5357 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, F3, FABP4, GSK3B, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.50242 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, BCL2, CDC25B, DHFR, EGFR, ESR1, F3, GSK3B, HSPA1A, INSR, PDE5A, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
3.46352 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.44341 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR, MAOB |
3.42743 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, BCL2, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TNKS, TNKS2, XDH |
3.42705 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
BCL2, CDK6, GSK3B, KDR, SMAD3, SRC, TEK |
3.42705 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, BCL2, CDK6, CYP1B1, FABP3, HSPA1A, IDO1, PDE5A, PTGS2, SMAD3, XDH |
3.42705 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
3.41938 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.41827 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, BCL2, CA1, CSNK2A1, EGFR, F3, GPR35, GSK3B, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.35809 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, BCL2, CDC25B, EGFR, ESRRB, INSR, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
3.35411 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
3.34493 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.32925 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F3, FABP4, IDO1, KDR, MET, PTGS2, SMAD3 |
3.32925 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, PTGS2, SRC |
3.31048 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.29781 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.29213 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
3.26348 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.26348 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
3.22712 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
BCL2, ESR1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.22178 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
EGFR, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
3.20819 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
3.20819 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
3.20819 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FUT7, GBA2, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
3.18993 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, BCL2, CA2, CA7, CYP19A1, EGFR, GPR35, GSK3B, HCAR2, HSPA1A, INSR, MAOB, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC |
3.18446 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
3.17782 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, CDK6, CYP1B1, EGFR, ESR1, GSK3B, IGF1R, INSR, MMP2, MMP9, PTGS2, SRC |
3.16752 |
[BP] GO:0050793 |
regulation of developmental process
|
BCL2, CA2, CDK6, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GSK3B, IDO1, INSR, KDR, NUAK1, PDE5A, PPARA, PTGS2, SMAD3, SRC, TEK, TNKS2, XDH |
3.13481 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, HSD11B2, MAOB, PTGS2 |
3.12381 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, GSK3B, HCAR2, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.11168 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
BCL2, CA2, CYP1B1, EGFR, ESRRB, F3, HCAR2, HSPA1A, IDO1, KDR, MET, MMP9, PDE5A, PTGS2, SMAD3, SRC, TEK |
3.09804 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, GPR35, MAOB, MMP9, PTGS2 |
3.09501 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2, GSK3B, HSPA1A, IDO1, MAOB, PDE5A, SRC, XDH |
3.09501 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, TYR |
3.07809 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, BCL2, CDC25B, DUSP3, EGFR, FABP4, IGF1R, INSR, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
3.06092 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.02357 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.99379 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, EGFR, HCAR2, PTGS2, TNKS, TNKS2 |
2.99171 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, F3, FABP4, GSK3B, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
2.99171 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.99171 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.98108 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.98108 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.98108 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.95875 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
2.94708 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, BCL2, CDC25B, EGFR, INSR, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
2.93931 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, BCL2, CDC25B, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
2.93178 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
EGFR, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
2.92149 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PTGS2, SMAD3, XDH |
2.92149 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.91762 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, GSK3B, HSD11B2, HSPA1A, IDO1, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
2.91762 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.90786 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGS2 |
2.90666 |
[BP] GO:0051701 |
interaction with host
|
EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
2.88194 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.88194 |
[BP] GO:0006091 |
generation of precursor metabolites and energy
|
AKR1B1, AOX1, CYP19A1, CYP1A2, GSK3B, IDO1, MAOB, XDH |
2.85866 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.85061 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, IGF1R, INSR, PDE5A, PTPN1, SRC |
2.83095 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, INSR, PPARA, SRC |
2.81732 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, PTGS2, SRC |
2.809 |
[BP] GO:0051098 |
regulation of binding
|
BCL2, GSK3B, MET, MMP9, PPARA, SMAD3, SRC, TNKS |
2.809 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
2.80274 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, HSPA1A, IDO1, MAOB, PDE5A, XDH |
2.79592 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.77114 |
[BP] GO:0016310 |
phosphorylation
|
BCL2, CDC25B, CDK6, CSNK2A1, EGFR, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
2.74912 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, DUSP3, EGFR, IGF1R, INSR, KDR, PDE5A, PTPN1, SRC, TEK, XDH |
2.7157 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.70403 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.68114 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, BCL2, CYP1B1, EGFR, MMP9, SRC |
2.67921 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, CDC25B, DUSP3, EGFR, FABP4, GSK3B, IGF1R, INSR, PDE5A, PTPN1, SRC, TEK, TNKS |
2.67839 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
2.67378 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.6704 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, HCAR2, PPARA, PTGS2, SRC, TEK |
2.65745 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, EGFR, HCAR2, MET, PPARA, SMAD3 |
2.65579 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.64815 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.64815 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
CDK6, GSK3B, KDR, SMAD3, TEK |
2.64412 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, IDO1, PPARA, PTGS2 |
2.6406 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.63883 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
BCL2, CSNK2A1, EGFR, F10, GSK3B, IGF1R, INSR, KDR, MET, SRC, TEK, TNKS |
2.63883 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.63117 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, BCL2, CA2, CDK6, CYP19A1, DUSP3, ESR1, ESRRA, HCAR2, HSPA1A, IDO1, MMP2, PDE5A, PTPN1, SMAD3, SRC |
2.62237 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, CYP1B1, EGFR, MMP9, SRC |
2.61502 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3, SRC |
2.61133 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ESR1, GSK3B, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.6046 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.60439 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGS2 |
2.60439 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.60439 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.58812 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.58812 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.58812 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, CYP1A1, CYP1A2, IDO1, MAOB, PTGS2, SRC |
2.54986 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
BCL2, GSK3B, HSPA1A, MMP9, PTGS2, PTPN1, SMAD3, SRC |
2.54903 |
[BP] GO:0043434 |
None
|
FABP3, HSD11B2, INSR, PPARA, PTGS2, SRC, TEK |
2.54461 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.53265 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.53265 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.51734 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, EGFR, ESR1, MET, SMAD3, SRC |
2.51444 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, CDK6, CYP1B1, EGFR, KDR, PTGS2, SRC |
2.51444 |
[BP] GO:0048511 |
rhythmic process
|
BCL2, CSNK2A1, EGFR, ESR1, GSK3B, PPARA, SRC |
2.49649 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.47753 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.47738 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.47738 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, EGFR, INSR, KDR, PDE5A, PTPN1, SRC, TEK, XDH |
2.47421 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, BCL2, CA1, CA12, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, GPR35, GSK3B, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.47 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, SRC |
2.46117 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, EGFR, PTGS2 |
2.42963 |
[BP] GO:0010675 |
None
|
ESRRB, GSK3B, INSR, PPARA, SRC |
2.42963 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.42513 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CYP1A1, CYP1B1, KDR, MAOB, SRC |
2.41485 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS2 |
2.40294 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, CYP1A1, CYP1A2, IDO1, MAOB, PTGS2, SRC |
2.40294 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, PPARA, PTGS2, SRC, TEK |
2.40294 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, EGFR, HSD11B2, PTGS2, SRC, TYR |
2.39798 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, PTGS2 |
2.38906 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
BCL2, CDC25B, CDK6, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, SMAD3, TNKS |
2.37997 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.37705 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.37672 |
[BP] GO:0043393 |
regulation of protein binding
|
BCL2, GSK3B, MET, MMP9, PPARA, SRC |
2.37211 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.34557 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.34557 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.34557 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, KDR, SRC |
2.34557 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
2.33894 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.33414 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, BCL2, CA2, CYP19A1, EGFR, GSK3B, HCAR2, INSR, PTGS2, SMAD3, SRC |
2.33058 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA |
2.32302 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.31806 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, BCL2, CDC25B, CDK6, CYP1A1, EGFR, ESR1, ESRRB, FABP4, FUT7, GBA2, GSK3B, KDR, MET, MMP2, MMP9, PTGS2, SMAD3, SRC, TEK |
2.30512 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.2995 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.29057 |
[BP] GO:0045932 |
None
|
ADORA1, PDE5A, PTGS2 |
2.29057 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.28974 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.28383 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.28383 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, EGFR, ESR1, GSK3B, IGF1R, INSR, MMP2, PTGS2, SMAD3, SRC |
2.28251 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
BCL2, CSNK2A1, DHFR, DUSP3, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, IGF1R, MET, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TNKS, TNKS2, XDH |
2.27244 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, IDO1 |
2.27155 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.27113 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, SRC |
2.27028 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.25554 |
[BP] GO:0005979 |
None
|
ESRRB, GSK3B, INSR |
2.25554 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.25554 |
[BP] GO:0010962 |
None
|
ESRRB, GSK3B, INSR |
2.25554 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, BCL2, CYP1A1, EGFR, HSD11B2, PTGS2, SRC, TYR |
2.25002 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, BCL2, CDK6, CYP1A1, CYP1A2, GSK3B, IDO1, MAOB, PTGS2, SMAD3, SRC |
2.21854 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, ESR1, F10, F3, FUT7, GSK3B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.21667 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, IGF1R, KDR, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TNKS, TNKS2, XDH |
2.21665 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.21313 |
[BP] GO:0032868 |
None
|
FABP3, HSD11B2, INSR, PPARA, SRC |
2.20778 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, CDC25B, DUSP3, EGFR, FABP4, IGF1R, INSR, PDE5A, PTPN1, SRC, TEK |
2.19983 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ESR1, GSK3B, HSPA1A, MET, MMP1, SRC |
2.19983 |
[BP] GO:0051726 |
regulation of cell cycle
|
BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PTGS2, SMAD3, SRC, TNKS |
2.19802 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
CSNK2A1, ESRRB, GSK3B, HSPA1A, INSR, KDR, PPARA, PTPN1 |
2.17867 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.17867 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.17867 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.17867 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.17867 |
[BP] GO:0050678 |
None
|
CDK6, EGFR, F3, KDR, SMAD3, TEK, XDH |
2.17867 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GBA2, IDO1, PPARA, PTGS2, TYR |
2.1689 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
BCL2, CA2, CDK6, CYP1B1, EGFR, ESR1, ESRRA, F3, GSK3B, IDO1, INSR, KDR, PTGS2, SMAD3, SRC, TEK, XDH |
2.16776 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, SRC, TNKS, TNKS2 |
2.15409 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.14066 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, BCL2, CDC25B, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.14066 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
CSNK2A1, EGFR, ESR1, F3, GSK3B, HSPA1A, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, XDH |
2.13518 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, GSK3B, TNKS |
2.10659 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, MAOB, TYR |
2.10659 |
[BP] GO:0051128 |
regulation of cellular component organization
|
BCL2, CSNK2A1, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.10423 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.10335 |
[BP] GO:0070873 |
None
|
ESRRB, GSK3B, INSR |
2.10335 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, BCL2, CDC25B, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.10283 |
[BP] GO:0008217 |
None
|
ADORA1, HSD11B2, PPARA, PTGS2, SMAD3 |
2.09645 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, GPR35, GSK3B, HCAR2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
2.09039 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, BCL2, CDC25B, EGFR, INSR, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
2.07367 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.06842 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.06842 |
[BP] GO:0043255 |
regulation of carbohydrate biosynthetic process
|
ESRRB, GSK3B, INSR, PPARA |
2.05598 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, EGFR, ESR1, PTGS2, SRC |
2.04255 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CYP1B1, F3, KDR, PTGS2, TEK |
2.04255 |
[BP] GO:1903426 |
None
|
EGFR, INSR, PTGS2, SMAD3 |
2.04255 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.04255 |
[BP] GO:0007162 |
negative regulation of cell adhesion
|
CYP1B1, DUSP3, IDO1, PDE5A, PPARA, SRC |
2.04255 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.04255 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.04255 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.04255 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
2.04034 |
[BP] GO:0003018 |
None
|
ADORA1, EGFR, PTGS2, SRC, TEK |
2.04034 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ALPL, BCL2, CDK6, CYP1A1, CYP1A2, EGFR, HSD11B2, IDO1, MAOB, PTGS2, SMAD3, SRC, TYR |
2.03828 |
[BP] GO:0051186 |
None
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, DHFR, EGFR, MAOB, PTGS2 |
2.03828 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, EGFR, ESR1, MET, SMAD3, SRC |
2.0283 |
[BP] GO:0032885 |
regulation of polysaccharide biosynthetic process
|
ESRRB, GSK3B, INSR |
2.01018 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, INSR, KDR, MAOB, MMP2, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TNKS, TNKS2, TYR, XDH |
3.09501 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.53265 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.04255 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPL, BCL2, CA12, CA14, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, F10, F3, FUT7, GBA2, GPR35, GSK3B, HCAR2, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MAOB, MET, MMP2, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR |
2.03828 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGS2 |
1.96102 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, F10, F3, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SRC, TEK, TNKS, TNKS2, TYR, XDH |
11.7383 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, PTPN1, SMAD3, TNKS, TYR, XDH |
10.0473 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, GSK3B, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
9.8807 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.15975 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, MAOB, PTGS2, TYR, XDH |
7.76567 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD11B2, HSD17B1, IDO1, MAOB, PTGS2, SRC, XDH |
5.69958 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, PTPN1, SMAD3, TNKS |
5.64342 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.28868 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.08266 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
4.83802 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, MAOB, XDH |
4.76486 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, IDO1, MMP1, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, TNKS, TNKS2, TYR, XDH |
4.4404 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.41821 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC |
4.33631 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
4.30077 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC |
4.13835 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
4.10757 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, IDO1, MMP1, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, TNKS, TNKS2, TYR, XDH |
3.98473 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.98473 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.98473 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.81624 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.7977 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.65754 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.64504 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.58187 |
[MF] GO:0008144 |
drug binding
|
ACHE, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PPARA, SRC, TEK |
3.57291 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.51116 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.47777 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.44325 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.42705 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, CDK6, CSNK2A1, DHFR, EGFR, FABP3, FABP4, GSK3B, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, SRC, TEK, XDH |
3.16752 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
3.08049 |
[MF] GO:0004672 |
protein kinase activity
|
CDK6, CSNK2A1, EGFR, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
3.01542 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
3.01008 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
2.98223 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.95875 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.95875 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TYR |
2.91762 |
[MF] GO:0008289 |
lipid binding
|
ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA |
2.91762 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, CDK6, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
2.91547 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.8888 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.85703 |
[MF] GO:0019899 |
enzyme binding
|
BCL2, CDC25B, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, GSK3B, HSPA1A, MET, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS2 |
2.84006 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.83575 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SMAD3 |
2.80855 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
2.79355 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, SMAD3, TEK |
2.61133 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, CDK6, CSNK2A1, DHFR, EGFR, GSK3B, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, SRC, TEK, XDH |
2.58812 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, CDK6, CSNK2A1, DHFR, EGFR, GSK3B, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, SRC, TEK, XDH |
2.58812 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.58599 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
2.56587 |
[MF] GO:0043168 |
anion binding
|
AOX1, CDK6, CSNK2A1, DHFR, EGFR, F10, F3, FABP3, FABP4, GSK3B, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, SRC, TEK, XDH |
2.547 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
CDK6, CSNK2A1, EGFR, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.43972 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, BCL2, CSNK2A1, EGFR, ESR1, ESR2, IGF1R, KDR, MAOB, MET, MMP9, PTGS2, SMAD3, TYR, XDH |
2.36601 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.34557 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.31383 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.25554 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.21313 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.17867 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.17867 |
[MF] GO:0016301 |
kinase activity
|
CDK6, CSNK2A1, EGFR, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.17661 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.06842 |
[MF] GO:0008013 |
beta-catenin binding
|
CSNK2A1, ESR1, GSK3B, SMAD3 |
2.04255 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, F10, F3, GSK3B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PTPN1, SRC, TEK |
2.04255 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.04255 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.04255 |